Literature DB >> 3779750

Protection of the ischaemic myocardium by L-propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation.

D J Paulson, J Traxler, M Schmidt, J Noonan, A L Shug.   

Abstract

The effects of L-propionylcarnitine on the recovery of cardiac contractile performance after global ischaemia and reperfusion were studied in isolated perfused rat hearts. The addition of either 5.5 or 11 mmol X litre-1 L-propionylcarnitine significantly improved the recovery of cardiac output, left ventricular pressure, and dP/dt after 90 min of ischaemia and 15 min of reperfusion. Myocardial adenosine triphosphate and creatine phosphate concentrations were significantly higher in the L-propionylcarnitine treated hearts than in controls, but the concentrations of long chain acyl carnitine and coenzyme A were unaffected. The protecting effects of L-propionylcarnitine were compared with those of L-carnitine and L-acetylcarnitine. A 11 mmol X litre-1 dose of L-propionylcarnitine and L-acetylcarnitine significantly improved the recovery of cardiac output after 90 min of ischaemia and 15 min of reperfusion, but L-carnitine did not. L-Propionylcarnitine was the most protective agent. The effects of these derivatives on L-3H-carnitine transport and 14C-palmitate oxidation were also measured. All of these derivatives competitively inhibited L-3H-carnitine transport in isolated cardiac myocytes, but L-propionylcarnitine was the most potent. Carnitine and L-propionylcarnitine stimulated palmitate oxidation in the homogenate, whereas L-acetylcarnitine inhibited it. In myocytes only L-propionylcarnitine affected palmitate oxidation. These data show that L-propionylcarnitine protects the ischaemic myocardium. Its protection is greater than that for L-carnitine or L-acetylcarnitine, and the difference in effectiveness may relate to the rate of transport into the cells and the effects on fatty acid utilisation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3779750     DOI: 10.1093/cvr/20.7.536

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  37 in total

1.  Biochemical profile of propionyl-L-carnitine.

Authors:  W C Hülsmann
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

2.  Effect of propionyl-L-carnitine on mechanical function of isolated rabbit heart.

Authors:  R Ferrari; E Pasini; E Condorelli; A Boraso; R Lisciani; A Marzo; O Visiou
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

3.  The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria.

Authors:  R Ferrari; C Ceconi; A Cargnoni; E Pasini; G M Boffa; S Curello; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

4.  Protective effects of propionyl-L-carnitine during ischemia and reperfusion.

Authors:  A Shug; D Paulson; R Subramanian; V Regitz
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

5.  Delineation of the influence of propionylcarnitine on the accumulation of long-chain acylcarnitines and electrophysiologic derangements evoked by hypoxia in canine myocardium.

Authors:  K A Yamada; D J Dobmeyer; E M Kanter; S G Priori; P B Corr
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

6.  Short-term hemodynamic effects of intravenous propionyl-L-carnitine in anesthetized dogs.

Authors:  A Cevese; F Schena; G Cerutti
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

Review 7.  Propionyl-L-carnitine: biochemical significance and possible role in cardiac metabolism.

Authors:  N Siliprandi; F Di Lisa; R Menabò
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

8.  Effect of prolonged treatment with propionyl-L-carnitine on erucic acid-induced myocardial dysfunction in rats.

Authors:  E Pasini; A Cargnoni; E Condorelli; A Marzo; R Lisciani; R Ferrari
Journal:  Mol Cell Biochem       Date:  1992-06-26       Impact factor: 3.396

9.  Effects of amino acids on substrate selection, anaplerosis, and left ventricular function in the ischemic reperfused rat heart.

Authors:  M E Jessen; T E Kovarik; F M Jeffrey; A D Sherry; C J Storey; R Y Chao; W S Ring; C R Malloy
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

10.  Carnitine deficiency and oxidative stress provoke cardiotoxicity in an ifosfamide-induced Fanconi Syndrome rat model.

Authors:  Mohamed M Sayed-Ahmed; Amal Q Darweesh; Amal J Fatani
Journal:  Oxid Med Cell Longev       Date:  2010 Jul-Aug       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.